Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-25 @ 2:56 AM
NCT ID:
NCT05208333
Eligibility Criteria:
Inclusion Criteria for phase 1 study:
* Pupils aged 3-15 years from Kindergarten to Secondary schools
* Agreement from parents with writen informed consent
Inclusion criteria for intervention:
* Children infected with toxocariasis may have symptoms and the ELISA test is positive for Toxocariasis larvae, with or without increased BCAT and IgE.
ELISA results according to the specified Kit and read according to optical densities (OD).
Cases of suspected heart, lung, liver, eye damage ... referred to Children's Hospital 2 for examination by specialty and not for intervention.
Exclusion Criteria:
* Children aged 3-15 years without writen informed consent from parents and themselves.
* Children infected with Toxocariasis larvae which are not common type.
* Children infected with Toxocariasis are suffering from acute diseases or other chronic diseases: Cardiovascular, hepatitis, kidney, stomach, mental, or suspected tumor...
* Children with a history of hypersensitivity to any ingredient in the treatment of Albendazole.
* Infected children do not have enough follow-up process before and after 1, 6 months of treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
15 Years
Study:
NCT05208333
Study Brief:
Protocol Section:
NCT05208333